233 related articles for article (PubMed ID: 25961436)
21. RNA interference and amyotrophic lateral sclerosis.
Rizvanov AA; Gulluoglu S; Yalvaç ME; Palotás A; Islamov RR
Curr Drug Metab; 2011 Sep; 12(7):679-83. PubMed ID: 21740381
[TBL] [Abstract][Full Text] [Related]
22. Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment.
Goodall EF; Morrison KE
Expert Rev Mol Med; 2006 May; 8(11):1-22. PubMed ID: 16723044
[TBL] [Abstract][Full Text] [Related]
23. Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trial.
Leigh PN; Swash M; Iwasaki Y; Ludolph A; Meininger V; Miller RG; Mitsumoto H; Shaw P; Tashiro K; Van Den Berg L
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Jun; 5(2):84-98. PubMed ID: 15204010
[TBL] [Abstract][Full Text] [Related]
24. Experimental therapies hold promise for treating amyotrophic lateral sclerosis.
Friedrich MJ
JAMA; 2005 Mar; 293(9):1048-9. PubMed ID: 15741517
[No Abstract] [Full Text] [Related]
25. Amyotrophic lateral sclerosis.
Feldman EL; Goutman SA; Petri S; Mazzini L; Savelieff MG; Shaw PJ; Sobue G
Lancet; 2022 Oct; 400(10360):1363-1380. PubMed ID: 36116464
[TBL] [Abstract][Full Text] [Related]
26. [Amyotrophic lateral sclerosis. Current clinical trials and underlying pathomechanisms].
Kollewe K; Dengler R; Petri S
Nervenarzt; 2008 Jun; 79(6):653-61. PubMed ID: 18210046
[TBL] [Abstract][Full Text] [Related]
27. Amyotrophic lateral sclerosis microgenomics.
Ravits J; Laurie P; Stone B
Phys Med Rehabil Clin N Am; 2005 Nov; 16(4):909-24, viii. PubMed ID: 16214051
[No Abstract] [Full Text] [Related]
28. Therapeutic advances in amyotrophic lateral sclerosis.
Louvel E; Hugon J; Doble A
Trends Pharmacol Sci; 1997 Jun; 18(6):196-203. PubMed ID: 9226998
[TBL] [Abstract][Full Text] [Related]
29. [Advances in the Development of Treatments for Amyotrophic Lateral Sclerosis].
Aoki M
Nihon Naika Gakkai Zasshi; 2016 Oct; 105(10):2055-62. PubMed ID: 30178967
[No Abstract] [Full Text] [Related]
30. Trial Tests Combined Cell and Gene Therapy for ALS.
Larkin HD
JAMA; 2022 Oct; 328(14):1387. PubMed ID: 36219418
[No Abstract] [Full Text] [Related]
31. Emerging targets and treatments in amyotrophic lateral sclerosis.
Zinman L; Cudkowicz M
Lancet Neurol; 2011 May; 10(5):481-90. PubMed ID: 21511200
[TBL] [Abstract][Full Text] [Related]
32. Guidelines in motor neurone disease (MND)/amyotrophic lateral sclerosis (ALS)--from diagnosis to patient care.
Mitchell JD
J Neurol; 2000 Dec; 247():7-12. PubMed ID: 11200703
[TBL] [Abstract][Full Text] [Related]
33. Amyotrophic lateral sclerosis and gene therapy.
Miller TM; Smith RA; Cleveland DW
Nat Clin Pract Neurol; 2006 Sep; 2(9):462-3. PubMed ID: 16932606
[No Abstract] [Full Text] [Related]
34. Learning from failed trials in ALS.
Swash M
Lancet Neurol; 2007 Dec; 6(12):1034-5. PubMed ID: 17980666
[No Abstract] [Full Text] [Related]
35. Multi-drug therapy in amyotrophic lateral sclerosis: the case for a multi-drug approach.
Rosenfeld J
Muscle Nerve; 2004 Nov; 30(5):673-5. PubMed ID: 15452840
[No Abstract] [Full Text] [Related]
36. Disease-modifying therapies in amyotrophic lateral sclerosis.
Chiò A; Mazzini L; Mora G
Neuropharmacology; 2020 May; 167():107986. PubMed ID: 32062193
[TBL] [Abstract][Full Text] [Related]
37. [Diagnostics and therapy for amyotrophic lateral sclerosis].
Grehl T
Fortschr Neurol Psychiatr; 2013 Oct; 81(10):592-603; quiz 604. PubMed ID: 24081520
[No Abstract] [Full Text] [Related]
38. Gene therapy for ALS delivers.
Boillée S; Cleveland DW
Trends Neurosci; 2004 May; 27(5):235-8. PubMed ID: 15111001
[TBL] [Abstract][Full Text] [Related]
39. Predictors of delay in the diagnosis and clinical trial entry of amyotrophic lateral sclerosis patients: a population-based study.
Zoccolella S; Beghi E; Palagano G; Fraddosio A; Samarelli V; Lamberti P; Lepore V; Serlenga L; Logroscino G;
J Neurol Sci; 2006 Dec; 250(1-2):45-9. PubMed ID: 16920152
[TBL] [Abstract][Full Text] [Related]
40. Guidelines in motor neurone disease (MND)/amyotrophic lateral sclerosis (ALS) - from diagnosis to patient care.
Mitchell JD
J Neurol; 2000 Dec; 247 Suppl 6():VI/7-12. PubMed ID: 19714406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
